These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38427958)
1. Increased Prostate-Specific Membrane Antigen Uptake in a Gallbladder Stone. Li H; Song L; Zhao M; Zhang W Clin Nucl Med; 2024 Apr; 49(4):344-345. PubMed ID: 38427958 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model. Alvim R; Nagar K; Das S; Lebdai S; Wong N; Somma A; Hughes C; Thomas J; Monette S; Scherz A; Kim K; Grimm J; Coleman JA Eur Urol Focus; 2021 Mar; 7(2):472-478. PubMed ID: 31227464 [TBL] [Abstract][Full Text] [Related]
4. Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre. Haran C; McBean R; Parsons R; Wong D J Med Imaging Radiat Oncol; 2019 Aug; 63(4):495-499. PubMed ID: 30972933 [TBL] [Abstract][Full Text] [Related]
5. A Multicenter Prospective Clinical Trial of McCarthy M; Francis R; Tang C; Watts J; Campbell A Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448 [TBL] [Abstract][Full Text] [Related]
6. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
7. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. Lenis AT; Pooli A; Lec PM; Sadun TY; Johnson DC; Lebacle C; Fendler WP; Eiber M; Czernin J; Reiter RE; Calais J Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451 [TBL] [Abstract][Full Text] [Related]
8. Risk of metastatic disease on Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer. Meijer D; Eppinga WSC; Mohede RM; Vanneste BGL; Meijnen P; Meijer OWM; Daniels LA; van den Bergh RCN; Lont AP; Ettema RH; Oudshoorn FHK; van Leeuwen PJ; van der Poel HG; Donswijk ML; Oprea-Lager DE; Schaake EE; Vis AN Eur Urol Oncol; 2022 Apr; 5(2):146-152. PubMed ID: 35074282 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer]. Veliev EI; Tomilov AA; Goncharuk DA; Bogdanov AB; Golubtsova EN Urologiia; 2018 Jul; (3):105-110. PubMed ID: 30035428 [TBL] [Abstract][Full Text] [Related]
15. Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative. McEwan LM; Wong D; Yaxley J J Med Imaging Radiat Oncol; 2017 Aug; 61(4):503-505. PubMed ID: 28349676 [TBL] [Abstract][Full Text] [Related]
16. Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review. Mattana F; Muraglia L; Rajwa P; Zattoni F; Marra G; Chiu PKF; Heidegger I; Kasivisvanathan V; Kesch CV; Olivier J; Preisser F; Thibault C; Valerio M; van den Bergh RCN; Gandaglia G; Ceci F; Eur Urol Oncol; 2023 Apr; 6(2):128-136. PubMed ID: 36804735 [TBL] [Abstract][Full Text] [Related]
17. Detection efficacy of [ Rosar F; Khreish F; Marlowe RJ; Schaefer-Schuler A; Burgard C; Maus S; Petto S; Bartholomä M; Ezziddin S Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2899-2909. PubMed ID: 37148297 [TBL] [Abstract][Full Text] [Related]
20. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]